TVTX compared with IVVD: revenue, margins and what each company keeps, and the suppliers and customers both name

TVTXTravere Therapeutics, Inc.

Mkt capRevenueRevenue

IVVDInvivyd, Inc.

Mkt capRevenueRevenue

Compare

TVTXTravere Therapeutics, Inc.

IVVDInvivyd, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TVTX 12

LGNDLigand Pharmaceuticalssupplier

—Catalent Pharma Solutionsunlistedsupplier

—Eversanaunlistedsupplier

—Mission Pharmacalunlistedsupplier

8 more · TVTX chain ›

Shared 0

No shared counterparties.

Only IVVD 9

—Undisclosed specialty distributor customerunlistedcustomer

—Adimabunlistedsupplier

—WuXi Biologicsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—WuXi Biologics (Hong Kong)unlistedsupplier

5 more · IVVD chain ›

TVTXTravere Therapeutics, Inc.

49.64▲+1.59%· post 49.64

Mkt cap$4.8BRevenue$225MQ3 FY26Revenue$491MFY25

IVVDInvivyd, Inc.

0.56▼−4.10%· post 0.56

ClosedNov 6 '26

Mkt cap$165.9MRevenue$14MQ2 FY26Revenue$53MFY25

Compare

ClosedNov 6 '26

TVTXTravere Therapeutics, Inc.

IVVDInvivyd, Inc.

49.64▲+1.59%post 49.64

Price

0.56▼−4.10%post 0.56

$4.8B

Mkt cap

$165.9M

Q3 FY26$225M

Revenue

$14MQ2 FY26

FY25$491M

Revenue

$53MFY25

TVTX49.64▲+1.59%vsIVVD0.56▼−4.10%ClosedNov 6 '26